The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TVTX FINANCIAL STATEMENTS

Travere Therapeutics Inc — balance sheet, income statement and cash flow trends

TVTXTravere Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue591.3 M $Gross Profit558.3 M $ · 94%Operating Income-40.5 M $ · -7%Pre-tax Income-67.1 M $ · -11%Net Income to Owners-43.5 M $ · -7%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue591.3 M $+77.1%
Gross Profit558.3 M $+72.6%
Operating Income-40.5 M $—
EBITDA1.5 M $—
Net Income to Owners-43.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets799.4 M
  • Equity24.5 M $3%
  • Current Liabilities152 M $19%
  • Long-term Liabilities622.8 M $78%

Key Figures

YoY change
Total Assets799.4 M $+43.9%
Total Liabilities774.8 M $+48.3%
Total Equity24.5 M $-25.1%
Cash & ST Investments489.2 M $+53.1%
Total Debt616.9 M $+54.4%
Net Debt499.2 M $+53.9%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M0100 M92.7 M $Operating-203 M $Investing153.1 M $Financing42.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow92.7 M $—
Capital Expenditures63.4 M $+112.8%
Free Cash Flow51.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TVTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.